BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30909144)

  • 1. RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a.
    Zhang L; Chen Y; Li C; Liu J; Ren H; Li L; Zheng X; Wang H; Han Z
    Biomed Pharmacother; 2019 Jun; 114():108772. PubMed ID: 30909144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.
    Hu R; Zhu X; Chen C; Xu R; Li Y; Xu W
    Cell Prolif; 2018 Dec; 51(6):e12508. PubMed ID: 30084199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA binding protein Lin28B confers gastric cancer cells stemness via directly binding to NRP-1.
    Wang X; Hu H; Liu H
    Biomed Pharmacother; 2018 Aug; 104():383-389. PubMed ID: 29787985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-binding protein PUM2 promotes T-cell acute lymphoblastic leukemia via competitively binding to RBM5 3'UTR with miR-28-5p.
    Bai T; Liu N
    Eur J Haematol; 2023 May; 110(5):498-509. PubMed ID: 36536516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
    Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
    Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-A/Neuropilin 1 Pathway Confers Cancer Stemness via Activating Wnt/β-Catenin Axis in Breast Cancer Cells.
    Zhang L; Wang H; Li C; Zhao Y; Wu L; Du X; Han Z
    Cell Physiol Biochem; 2017; 44(3):1251-1262. PubMed ID: 29179185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-376a inhibits breast cancer cell progression by targeting neuropilin-1 NR.
    Zhang L; Chen Y; Wang H; Zheng X; Li C; Han Z
    Onco Targets Ther; 2018; 11():5293-5302. PubMed ID: 30214235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells.
    Zhu H; Jiang X; Zhou X; Dong X; Xie K; Yang C; Jiang H; Sun X; Lu J
    Liver Int; 2018 Jan; 38(1):125-135. PubMed ID: 28618167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-Binding Protein Dnd1 Promotes Breast Cancer Apoptosis by Stabilizing the Bim mRNA in a miR-221 Binding Site.
    Cheng F; Pan Y; Lu YM; Zhu L; Chen S
    Biomed Res Int; 2017; 2017():9596152. PubMed ID: 28191469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling.
    Zhao Q; Liu Y; Wang T; Yang Y; Ni H; Liu H; Guo Q; Xi T; Zheng L
    Eur J Pharmacol; 2020 Oct; 884():173359. PubMed ID: 32738343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PUM2 Promotes Glioblastoma Cell Proliferation and Migration via Repressing BTG1 Expression.
    Wang Y; Sun W; Yang J; Yang L; Li C; Liu H; Liu X; Jiao B
    Cell Struct Funct; 2019; 44(1):29-39. PubMed ID: 30787206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis.
    Wu J; Zhao W; Wang Z; Xiang X; Zhang S; Liu L
    J Cell Mol Med; 2019 Jan; 23(1):680-688. PubMed ID: 30394668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
    Zheng L; Li X; Gu Y; Lv X; Xi T
    Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.
    Naik A; Al-Yahyaee A; Abdullah N; Sam JE; Al-Zeheimi N; Yaish MW; Adham SA
    BMC Cancer; 2018 May; 18(1):533. PubMed ID: 29728077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells.
    Gao L; Guo Q; Li X; Yang X; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Xi T; Zheng L
    EBioMedicine; 2019 Mar; 41():395-407. PubMed ID: 30803931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
    Gong F; Dong D; Zhang T; Xu W
    Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.